Clinical trials: Newly Diagnosed Breast Cancer
Breast Cancer, Breast Cancer and Rehabilitation
Cancer Patient Navigation and Readiness
This study evaluated whether Cancer Patient Navigation (CPN) services could improve readiness for the transition from breast cancer diagnosis to treatment.
- Conditions
- Breast Cancer, Breast Cancer and Rehabilitation, Transition Care, Breast Cancer - Female
- Trial name
- CPN Readiness (NCT07892157)
- Testing
- Cancer Patient Navigation Services
- Where
- Indonesia
- Volunteers
- 64 people
- Sponsor
- Universitas Muhammadiyah Semarang
Breast Cancer Females, Newly Diagnosed Breast Cancer
Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care.
- Trial name
- NCT07434817
- Testing
- Sexual Health Educational Video Series, Standard Care (in control arm)
- Where
- 4 sites in United States
- Volunteers
- 200 people
- Sponsor
- University of Colorado, Denver
Newly Diagnosed Triple-negative Breast Cancer
A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Intensified Therapy for Patients With Residual Disease After Neoadjuvant Treatment for Triple-negative Breast Cancer
This study is a multicenter, randomized controlled phase III clinical trial. The aim of this study is to observe the efficacy and safety of PD-1 inhibitors combined with capecitabine, PD-1 inhibitors alone, or capecitabine alone…
- Trial name
- CREATE (NCT07869628)
- Testing
- Capecitabine and PD-1 inhibitor, PD-1 inhibitor, Capecitabine
- Volunteers
- 852 people
- Sponsor
- Shandong Cancer Hospital and Institute
Glioblastoma, Melanoma Stage IV
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
This is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in patients with advanced solid tumors.
- Conditions
- Glioblastoma, Melanoma Stage IV, Breast Cancer, Prostate Cancer
- Trial name
- NCT04478279
- Testing
- ST101, Temozolomide, Radiation
- Where
- 11 sites in United States, United Kingdom
- Volunteers
- 125 people
- Sponsor
- Sapience Therapeutics
Breast Cancer, Newly Diagnosed Breast Cancer
Circulating miRNAs.
To identify a panel of circulating miRNA markers which could help identify those breast cancer patients who are most likely to respond well to neoadjuvant and adjuvant chemotherapy, and indeed serve as an overall prognostic…
- Conditions
- Breast Cancer, Newly Diagnosed Breast Cancer, Recurrent Breast Cancer
- Trial name
- NCT01722851
- Where
- 7 sites in Ireland
- Volunteers
- 255 people
- Sponsor
- Cancer Trials Ireland
Breast Cancer, Non-metastatic
Shared Decision Making on Care Pathways and CAMs: A Pilot Study
Shared Decision Making on Care Pathways and alternative and complementary medicine (CAMs) : A Pilot Study. Study whose aim is to evaluate the feasibility of a study proposing a therapeutic education consultation leaning on the…
- Conditions
- Breast Cancer, Non-metastatic, Newly Diagnosed, Feasibility Study
- Trial name
- NCT05388734
- Testing
- alternative medicine education consultation
- Where
- 2 sites in France
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University Hospital, Grenoble
Newly Diagnosed Breast Cancer
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care.
- Trial name
- NCT03510988
- Testing
- Hybrid breast FDG PET/MRI
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Weill Medical College of Cornell University
HER2-positive Newly Diagnosed, Primary Breast Cancer
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer
This randomized, parallel cohort, two stage, double-blind, placebo-controlled study evaluated the oral PI3K inhibitor BKM120 in combination with trastuzumab and paclitaxel in HER2-positive, PIK3CA wild-type and PIK3CA mutant…
- Trial name
- NeoPHOEBE (NCT01816594)
- Testing
- BKM120, Trastuzumab, Paclitaxel
- Where
- 7 sites in Australia, Austria and 2 more
- Volunteers
- 50 people
- Sponsor
- Novartis Pharmaceuticals
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
The purpose of the study is to see if tumors respond to endocrine therapy by taking a total of 21 doses of Tamoxifen before and after surgery.
- Trial name
- POWER PIINC (NCT01614210)
- Testing
- Tamoxifen, Breast cancer surgery
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- University of Utah
Newly Diagnosed Breast Cancer
A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
The purpose of this study is to provide the physicians with quality long term follow up data on subjects from the Breast Cancer Clinic and the Plastic Surgery Clinic who have been newly diagnosed with breast cancer and will…
- Trial name
- NCT01176838
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Wake Forest University
Newly Diagnosed Carcinoma of Breast, Genetic Predisposition to Disease
4R for Guideline Indicated BRCA Testing of Breast Center Patients
Currently, many breast center patients with a positive family history receive information about BRCA testing after breast cancer diagnosis, typically after definitive breast surgery or at a time point that does not allow them to…
- Trial name
- 4R (NCT01320540)
- Where
- United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Northwestern University
Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
This study is for adult females who have been newly diagnosed with breast cancer that includes surgery as part of standard cancer treatment.
- Trial name
- NCT01816555
- Testing
- Vitamin D
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Medical University of South Carolina
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill cancer cells.
- Conditions
- Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases, Carcinoma of the Appendix
- Trial name
- NCT00004074
- Testing
- recombinant interleukin-12, ABI-007/carboplatin/trastuzumab
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- National Cancer Institute (NCI)
The Role of Multimedia on Retention and Comprehension of Key Concepts for Surgical Options in Newly Diagnosed Breast Cancer Patients.
Evaluation of the Use of Multimedia to Enhance Patient and Family Understanding
This study will investigate the potential impact of arts-informed, technology-based patient education material, and specifically, the role of multimedia imagery on patient comprehension, perceived satisfaction, anxiety levels…
- Trial name
- NCT01152775
- Testing
- This group of patients will be exposed to multimedia, No Media
- Where
- 2 sites in Canada
- Volunteers
- 60 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Newly Diagnosed Breast Cancer, Surgery Programmed
Factors Correlated With Fatigue in Breast Cancer
The aim of this study is to identify the determinants of cancer-related fatigue, and the long-term effect of the different adjuvants treatments will be explored.
- Trial name
- FATSEIN (NCT01064427)
- Where
- 3 sites in France
- Volunteers
- 557 people
- Sponsor
- Central Hospital, Nancy, France